• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

适配体:癌症成像、诊断和治疗的有前途的工具。

Aptamers: a promising tool for cancer imaging, diagnosis, and therapy.

机构信息

Institute for Laboratory Medicine, Fuzhou General Hospital, PLA, Fuzhou, Fujian 350025, P.R. China.

出版信息

J Cell Biochem. 2013 Feb;114(2):250-5. doi: 10.1002/jcb.24373.

DOI:10.1002/jcb.24373
PMID:22949372
Abstract

Aptamers are a group of molecules, which can specifically bind, track, and inhibit target molecules, comprising DNA aptamers, RNA aptamers, and peptide aptamers. So far, there are much progress about developing novel aptamers and their expansile applications. This prospect systematically introduces the composition and technological evolution of aptamers, and then focuses on the application of aptamers in cancer diagnosis, imaging, and therapy. Following this, we discuss the potential to harness aptamers in discovering the biomarker of stem cells, which is favorable for us to study the normal developmental or abnormal pathological process of tissue and to deliver drugs into target cells or tissues in the future.

摘要

适配体是一组能够特异性结合、跟踪和抑制靶分子的分子,包括 DNA 适配体、RNA 适配体和肽适配体。到目前为止,开发新型适配体及其广泛应用方面已经取得了很大的进展。本文系统地介绍了适配体的组成和技术演变,然后重点介绍了适配体在癌症诊断、成像和治疗中的应用。接下来,我们讨论了利用适配体发现干细胞标志物的潜力,这有利于我们研究组织的正常发育或异常病理过程,并在未来将药物递送到靶细胞或组织中。

相似文献

1
Aptamers: a promising tool for cancer imaging, diagnosis, and therapy.适配体:癌症成像、诊断和治疗的有前途的工具。
J Cell Biochem. 2013 Feb;114(2):250-5. doi: 10.1002/jcb.24373.
2
The application of aptamers in cancer research: an up-to-date review.适体在癌症研究中的应用:最新综述。
Future Oncol. 2013 Mar;9(3):369-76. doi: 10.2217/fon.12.201.
3
Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy.生物技术、诊断和治疗中的功能性适体与核酸酶。
Chem Rev. 2007 Sep;107(9):3715-43. doi: 10.1021/cr0306743. Epub 2007 Aug 23.
4
Complex target SELEX.复杂靶标指数富集的配体系统进化技术
Acc Chem Res. 2008 Jan;41(1):130-8. doi: 10.1021/ar700142z.
5
Applications of aptamers in cancer cell biology.适体在癌细胞生物学中的应用。
Anal Chim Acta. 2008 Jul 28;621(2):101-8. doi: 10.1016/j.aca.2008.05.031. Epub 2008 May 21.
6
Nanoparticle-aptamer conjugates for cancer cell targeting and detection.用于癌细胞靶向和检测的纳米颗粒适配体缀合物。
Methods Mol Biol. 2010;624:235-48. doi: 10.1007/978-1-60761-609-2_16.
7
Nucleic acid aptamers targeting cell-surface proteins.靶向细胞表面蛋白的核酸适体。
Methods. 2011 Jun;54(2):215-25. doi: 10.1016/j.ymeth.2011.02.002. Epub 2011 Feb 12.
8
Aptamer-modified nanoparticles and their use in cancer diagnostics and treatment.适配子修饰的纳米颗粒及其在癌症诊断和治疗中的应用。
Swiss Med Wkly. 2014 Jan 6;144:w13908. doi: 10.4414/smw.2014.13908.
9
Nanotechnology and aptamers: applications in drug delivery.纳米技术与适配体:在药物递送中的应用
Trends Biotechnol. 2008 Aug;26(8):442-9. doi: 10.1016/j.tibtech.2008.04.006. Epub 2008 Jun 19.
10
Aptamers in targeted nanotherapy.适体在靶向纳米治疗中的应用。
Curr Top Med Chem. 2015;15(12):1102-14. doi: 10.2174/1568026615666150413153525.

引用本文的文献

1
Harnessing nanotechnology for cancer treatment.利用纳米技术治疗癌症。
Front Bioeng Biotechnol. 2025 Jan 20;12:1514890. doi: 10.3389/fbioe.2024.1514890. eCollection 2024.
2
Targeting the SOX2/CDP protein complex with a peptide suppresses the malignant progression of esophageal squamous cell carcinoma.用一种肽靶向SOX2/CDP蛋白复合物可抑制食管鳞状细胞癌的恶性进展。
Cell Death Discov. 2023 Oct 27;9(1):399. doi: 10.1038/s41420-023-01693-7.
3
Ultra pH-sensitive detection of total and free prostate-specific antigen using electrochemical aptasensor based on reduced graphene oxide/gold nanoparticles emphasis on TiO/carbon quantum dots as a redox probe.
基于还原氧化石墨烯/金纳米粒子并以TiO/碳量子点作为氧化还原探针的电化学适体传感器用于超pH敏感检测总前列腺特异性抗原和游离前列腺特异性抗原
Eng Life Sci. 2021 Aug 22;21(11):739-752. doi: 10.1002/elsc.202000118. eCollection 2021 Nov.
4
Selection of DNA Aptamers for Differentiation of Human Adipose-Derived Mesenchymal Stem Cells from Fibroblasts.用于区分人脂肪间充质干细胞与成纤维细胞的 DNA 适体的选择。
Appl Biochem Biotechnol. 2021 Nov;193(11):3704-3718. doi: 10.1007/s12010-021-03618-5. Epub 2021 Aug 6.
5
Targeting SOX2 Protein with Peptide Aptamers for Therapeutic Gains against Esophageal Squamous Cell Carcinoma.靶向 SOX2 蛋白的肽适体在治疗食管鳞癌中的应用。
Mol Ther. 2020 Mar 4;28(3):901-913. doi: 10.1016/j.ymthe.2020.01.012. Epub 2020 Jan 15.
6
Development of a novel ssDNA aptamer targeting neutrophil gelatinase-associated lipocalin and its application in clinical trials.开发一种针对中性粒细胞明胶酶相关载脂蛋白的新型 ssDNA 适体及其在临床试验中的应用。
J Transl Med. 2019 Jun 18;17(1):204. doi: 10.1186/s12967-019-1955-7.
7
In Vitro Selection of a DNA Aptamer by Cell-SELEX as a Molecular Probe for Cervical Cancer Recognition and Imaging.通过细胞 SELEX 体外选择 DNA 适体作为宫颈癌识别和成像的分子探针。
J Mol Evol. 2019 Apr;87(2-3):72-82. doi: 10.1007/s00239-019-9886-8. Epub 2019 Jan 19.
8
Selective Targeting to Glioma with Nucleic Acid Aptamers.用核酸适配体对胶质瘤进行选择性靶向
PLoS One. 2015 Aug 7;10(8):e0134957. doi: 10.1371/journal.pone.0134957. eCollection 2015.
9
Smart functional nucleic acid chimeras: enabling tissue specific RNA targeting therapy.智能功能性核酸嵌合体:实现组织特异性RNA靶向治疗
RNA Biol. 2015;12(4):412-25. doi: 10.1080/15476286.2015.1017234.
10
New Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization.新技术在 SELEX 方法和适体表征的规模、速度和成功率方面带来了量子级的变化。
Mol Ther Nucleic Acids. 2014 Aug 5;3(8):e183. doi: 10.1038/mtna.2014.34.